Global Market

Multiple Sclerosis

2022: 25.9 bUSD
2030: 34.36 bUSD (CAGR 3.6%)

Diabetes Type 1

2022: 7.59 bUSD
2030: 13.64 bUSD (CAGR 7.6%) ^[1,2]